Skip to search formSkip to main contentSkip to account menu

clavam

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Tazobactam, sulbactam, and clavulanic acid are the only beta-lactamase inhibitors in clinical use. Comparative inhibitory… 
Highly Cited
2005
Highly Cited
2005
The enzyme-catalysed reactions involved in formation of the bicyclic clavam and carbapenem nuclei, including beta-amino acid and… 
2004
2004
ABSTRACT Past genetic studies have indicated that the genes encoding early enzymes of clavulanic acid biosynthesis may be… 
2002
2002
During biosynthesis of the clinically used beta-lactamase inhibitor clavulanic acid, one of the three steps catalysed by… 
2001
2001
ABSTRACT Cephamycin C production was blocked in wild-type cultures of the clavulanic acid-producing organism Streptomyces… 
Review
2000
Review
2000
Clavulanic acid is a secondary metabolite produced by Streptomyces clavuligerus. It possesses a clavam structure and a… 
Review
1999
Review
1999
Beta-Lactamases of Ambler's Class A are the most commonly encountered mechanism of bacterial resistance to beta-lactam… 
1995
1995
Clavaminate synthase (CS), a key enzyme in the clavulanic acid biosynthetic pathway, has been purified to electrophoretic… 
1991
1991
(2R,5S)-2-Hydroxymethyl-1-carbapenam (3), the carba-analog of an antifungal beta-lactam (2R,5S)-2-(hydroxymethyl)calvam (1), was… 
1983
1983
The complete stereostructure of the new antibiotic Ro 22-5417 has been established as 3-[(3S,5S)-7-oxo-1-aza-4-oxabicyclo[3.2.O…